The U.S. Food and Drug Administration (FDA) Nanotechnology Task Force is celebrating NanoDay on October 9, 2020, by hosting a virtual research symposium to showcase more than a decade of progress and innovation in nanotechnology at FDA.  The agenda lists the following presentations:

• A Decade of Progress and Innovation in Nanotechnology at U.S. FDA;

• Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology;

• Regulatory Science Research in Nanotechnology;

• Drug Products That Contain Nanomaterials;

• Nanotechnology and Medical Devices: A Regulatory Science Approach Involving Research, Standards, and Risk Assessment;

• Food Ingredients and Food Contact Substances Containing Nanomaterials: Guidance for Manufacturing Process Change;

• Use of Nanomaterials in Foods and Drugs for Animals;

• Virtual Tour of the Nanocore Facilities (five-minute video);

• Biological Products That Contain Nanomaterials;

• Office of Regulatory Affairs (ORA) and Nanomaterials;

• Safety of Nanomaterials in Cosmetic Products;

• Liposome Drug Products Guidance;

• Standards in Nanotechnology;

• Collaborative Opportunities for Research Excellence in Science (CORES) Intramural Grants Program; and

• Highlights of Nanotechnology Research at FDA.

Registration is now open.